Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Ribeiro, Ricardo ^a,b,c   Monteiro, Cátia ^a,c   Cunha, Virgínia ^a,c   Oliveira, Maria ^d,e   Freitas, Mariana ^f,g   Fraga, Avelino ^h   Príncipe, Paulo ^h   Lobato, Carlos ⁱ   Lobo, Francisco ^a   Morais, Antánio ^a   Silva, Vítor ^a   Sanches Magalhães, José ^a   Oliveira, Jorge ^a   Pina, Francisco ^j   Mota Pinto, Anabela ^f   Lopes, Carlos ^b   Medeiros, Rui ^a,b,c  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c LPCC   (Portugal)

^d INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^e Inst of Pharmacol and Therapeutics   (Portugal)

^f UNIVERSITY OF COIMBRA   (Portugal)

^g UNIVERSITY OF COIMBRA   (Portugal)

^h Centro Hospitalar Universitario do Porto   (Portugal)

ⁱ Porto Military Hospital   (Portugal)

^j HOSPITAL DE SÃO JOÃO   (Portugal)

more..

Author keywords

Adipose tissue; Cell line; Cell proliferation; Cell tracking; Obesity; Periprostatic; Prostate cancer

Indexed keywords

GELATINASE A; GELATINASE B;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; BLOOD VESSEL PARAMETERS; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL STRAIN PC 3; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; STROMAL VASCULAR FRACTION;

ADIPOSE TISSUE; AGED; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OBESITY; PROSTATIC NEOPLASMS;

EID: 85027938362     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-32     Document Type: Article

References (64)

1. Park J, Euhus DM, Scherer PE: Paracrine and Endocrine Effects of Adipose Tissue on Cancer Development and Progression. Endocr Rev 2011, 32:550-570.
2. van Kruijsdijk RC, van der Wall E, Visseren FL: Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009, 18:2569-2578.
3. Capitanio U, Suardi N, Briganti A, Gallina A, Abdollah F, Lughezzani G, Salonia A, Freschi M, Montorsi F: Influence of obesity on tumour volume in patients with prostate cancer. BJU Int 2011, 109:678-684.
4. Freedland SJ, Banez LL, Sun LL, Fitzsimons NJ, Moul JW: Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate Cancer Prostatic Dis 2009, 12:259-263.
5. Cheng L, Darson MF, Bergstralh EJ, Slezak J, Myers RP, Bostwick DG: Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer 1999, 86:1775-1782. (Pubitemid 29513047)
6. Valastyan S, Weinberg RA: Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
7. Finley DS, Calvert VS, Inokuchi J, Lau A, Narula N, Petricoin EF, Zaldivar F, Santos R, Tyson DR, Ornstein DK: Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. J Urol 2009, 182:1621-1627.
8. van Roermund JG, Hinnen KA, Tolman CJ, Bol GH, Witjes JA, Bosch JL, Kiemeney LA, van Vulpen M: Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients. BJU Int 2011, 107:1775-1779.
9. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, et al: Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011, 17:1498-1503.
10. Schnabele K, Roser S, Rechkemmer G, Hauner H, Skurk T: Effects of adipocyte-secreted factors on cell cycle progression in HT29 cells. Eur J Nutr 2009, 48:154-161.
11. Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, et al: Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011, 71:2455-2465.
12. Onuma M, Bub JD, Rummel TL, Iwamoto Y: Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem 2003, 278:42660-42667. (Pubitemid 37310540)
13. Tokuda Y, Satoh Y, Fujiyama C, Toda S, Sugihara H, Masaki Z: Prostate cancer cell growth is modulated by adipocyte-cancer cell interaction. BJU Int 2003, 91:716-720. (Pubitemid 36583750)
14. Somasundar P, Yu AK, Vona-Davis L, McFadden DW: Differential effects of leptin on cancer in vitro. J Surg Res 2003, 113:50-55. (Pubitemid 36999792)
15. Ribeiro RJ, Monteiro CP, Cunha VF, Azevedo AS, Oliveira MJ, Monteiro R, Fraga AM, Principe P, Lobato C, Lobo F, et al: Tumor Cell-educated Periprostatic Adipose Tissue Acquires an Aggressive Cancer-promoting Secretory Profile. Cell Physiol Biochem 2012, 29:233-240.
16. Thalmann S, Juge-Aubry CE, Meier CA: Explant cultures of white adipose tissue. Methods Mol Biol 2008, 456:195-199.
17. Desbois D, Couturier E, Mackiewicz V, Graube A, Letort MJ, Dussaix E, Roque-Afonso AM: Epidemiology and genetic characterization of hepatitis A virus genotype IIA. J Clin Microbiol 2010, 48:3306-3315.
18. Albertsen PC, Hanley JA, Fine J: 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005, 293:2095-2101. (Pubitemid 40617061)
19. Taichman RS, Loberg RD, Mehra R, Pienta KJ: The evolving biology and treatment of prostate cancer. J Clin Invest 2007, 117:2351-2361. (Pubitemid 47494332)
20. Chung LW, Baseman A, Assikis V, Zhau HE: Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 2005, 173:10-20. (Pubitemid 39627663)
21. Notarnicola M, Miccolis A, Tutino V, Lorusso D, Caruso MG: Low levels of lipogenic enzymes in peritumoral adipose tissue of colorectal cancer patients. Lipids 2012, 47:59-63.
22. Unal R, Yao-Borengasser A, Varma V, Rasouli N, Labbate C, Kern PA, Ranganathan G: Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone. J Clin Endocrinol Metab 2010, 95:2993-3001.
23. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174. (Pubitemid 37328786)
24. Lichtinghagen R, Musholt PB, Stephan C, Lein M, Kristiansen G, Hauptmann S, Rudolph B, Schnorr D, Loening SA, Jung K: mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue. Anticancer Res 2003, 23:2617-2624. (Pubitemid 36897135)
25. Chakrabarti S, Patel KD: Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res 2005, 31:599-621. (Pubitemid 40967244)
26. Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, Lee MT: Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci 2011, 102:815-827.
27. Allott EH, Lysaght J, Cathcart MC, Donohoe CL, Cummins R, McGarrigle SA, Kay E, Reynolds JV, Pidgeon GP: MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation. Mol Carcinog 2011, doi: 10.1002/ mc.21840.
28. Trayhurn P: Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005, 184:285-293.
29. Mistry T, Digby JE, Desai KM, Randeva HS: Obesity and prostate cancer: a role for adipokines. Eur Urol 2007, 52:46-53. (Pubitemid 46803036)
30. Ribeiro R, Lopes C, Medeiros R: The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives. Prostate Cancer Prostatic Dis 2006, 9:19-24. (Pubitemid 43378863)
31. Hoda MR, Popken G: Mitogenic and anti-apoptotic actions of adipocyte-derived hormone leptin in prostate cancer cells. BJU Int 2008, 102:383-388. (Pubitemid 352019186)
32. Chung TD, Yu JJ, Spiotto MT, Bartkowski M, Simons JW: Characterization of the role of IL-6 in the progression of prostate cancer. Prostate 1999, 38:199-207. (Pubitemid 29054936)
33. Mori S, Murakami-Mori K, Bonavida B: Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells. Biochem Biophys Res Commun 1999, 257:609-614. (Pubitemid 29301490)
34. Iwamura M, Sluss PM, Casamento JB, Cockett AT: Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate 1993, 22:243-252. (Pubitemid 23184735)
35. Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T: Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line. J Urol 2000, 164:800-805. (Pubitemid 30637637)
36. Chopra DP, Menard RE, Januszewski J, Mattingly RR: TNF-alpha-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett 2004, 203:145-154. (Pubitemid 38058682)
37. Mistry T, Digby JE, Chen J, Desai KM, Randeva HS: The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun 2006, 348:832-838. (Pubitemid 44233495)
38. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL: Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109:1292-1298. (Pubitemid 38372789)
39. Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Gyori G, Zlabinger GJ, Stulnig TM: Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) 2007, 31:1420-1428. (Pubitemid 47339934)
40. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM: Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2007, 293:E656-665. (Pubitemid 47358976)
41. Kharait S, Dhir R, Lauffenburger D, Wells A: Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells. Biochem Biophys Res Commun 2006, 343:848-856.
42. Mohler JL: Cellular motility and prostatic carcinoma metastases. Cancer Metastasis Rev 1993, 12:53-67.
43. Chen J: Multiple signal pathways in obesity-associated cancer. Obes Rev 2011, 12:1063-1070.
44. Wells A, Gupta K, Chang P, Swindle S, Glading A, Shiraha H: Epidermal growth factor receptor-mediated motility in fibroblasts. Microsc Res Tech 1998, 43:395-411. (Pubitemid 28565787)
45. Desai B, Ma T, Chellaiah MA: Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion. J Biol Chem 2008, 283:13856-13866.
46. Subramaniam V, Vincent IR, Jothy S: Upregulation and dephosphorylation of cofilin: modulation by CD44 variant isoform in human colon cancer cells. Exp Mol Pathol 2005, 79:187-193. (Pubitemid 41566231)
47. Huang CY, Yu HS, Lai TY, Yeh YL, Su CC, Hsu HH, Tsai FJ, Tsai CH, Wu HC, Tang CH: Leptin increases motility and integrin up-regulation in human prostate cancer cells. J Cell Physiol 2011, 226:1274-1282.
48. Tang CH, Lu ME: Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways. Prostate 2009, 69:1781-1789.
49. Im E, Motiejunaite R, Aranda J, Park EY, Federico L, Kim TI, Clair T, Stracke ML, Smyth S, Kazlauskas A: Phospholipase Cgamma activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression. Mol Cell Biol 2010, 30:2401-2410.
50. Takahashi M, Ota S, Hata Y, Ogura K, Kurita M, Terano A, Nakamura T, Omata M: Constitutive expression of hepatocyte growth factor may maintain the sheet construction of gastric epithelial cells through facilitating actin-myosin contractile system. Biochem Biophys Res Commun 1996, 219:40-46.
51. Kinoshita M, Shimokado K: Autocrine FGF-2 is responsible for the cell density- dependent susceptibility to apoptosis of HUVEC: A role of a calpain inhibitor-sensitive mechanism. Arterioscler Thromb Vasc Biol 1999, 19:2323-2329. (Pubitemid 29477832)
52. Hoang MV, Nagy JA, Fox JE, Senger DR: Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis. PLoS One 2010, 5:e13612.
53. Taraboletti G, Roberts DD, Liotta LA: Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol 1987, 105:2409-2415. (Pubitemid 18019089)
54. Wang JM, Taraboletti G, Matsushima K, Van Damme J, Mantovani A: Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem Biophys Res Commun 1990, 169:165-170. (Pubitemid 20181008)
55. Ferry G, Tellier E, Try A, Gres S, Naime I, Simon MF, Rodriguez M, Boucher J, Tack I, Gesta S, et al: Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J Biol Chem 2003, 278:18162-18169. (Pubitemid 36799431)
56. Azare J, Doane A, Leslie K, Chang Q, Berishaj M, Nnoli J, Mark K, Al- Ahmadie H, Gerald W, Hassimi M, et al: Stat3 mediates expression of autotaxin in breast cancer. PLoS One 2011, 6:e27851.
57. Geho DH, Bandle RW, Clair T, Liotta LA: Physiological mechanisms of tumor-cell invasion and migration. Physiology (Bethesda) 2005, 20:194-200. (Pubitemid 40807057)
58. Khandekar MJ, Cohen P, Spiegelman BM: Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011, 11:886-895.
59. O'Hara A, Lim FL, Mazzatti DJ, Trayhurn P: Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is upregulated in human adipocytes by macrophage-conditioned medium. Pflugers Arch 2009, 458:1103-1114.
60. Wu Y, Smas CM: Wdnm1-like, a new adipokine with a role in MMP-2 activation. Am J Physiol Endocrinol Metab 2008, 295:E205-215.
61. Patel ST, Mistry T, Brown JE, Digby JE, Adya R, Desai KM, Randeva HS: A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis. Peptides 2010, 31:51-57.
62. Andarawewa KL, Motrescu ER, Chenard MP, Gansmuller A, Stoll I, Tomasetto C, Rio MC: Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 2005, 65:10862-10871. (Pubitemid 41713354)
63. Toda S, Uchihashi K, Aoki S, Sonoda E, Yamasaki F, Piao M, Ootani A, Yonemitsu N, Sugihara H: Adipose tissue-organotypic culture system as a promising model for studying adipose tissue biology and regeneration. Organogenesis 2009, 5:50-56.
64. Sung SY, Chung LW: Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting. Differentiation 2002, 70:506-521.